China Resources Double-Crane Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Q94
CNY
18.87
0.12 (0.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
11,067.33
11,165.48
9,504.60
8,995.77
8,389.52
9,244.12
8,077.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
11,067.33
11,165.48
9,504.60
8,995.77
8,389.52
9,244.12
8,077.96
Raw Material Cost
5,050.55
5,111.79
4,598.11
4,282.42
3,322.60
3,586.84
3,152.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.77
16.97
11.95
12.55
4.21
10.55
9.32
Selling and Distribution Expenses
3,889.69
3,732.04
3,295.44
3,339.78
3,652.57
4,242.32
3,670.65
Other Expenses
53.84
61.09
35.35
31.74
24.32
16.34
11.67
Total Expenditure (Excl Depreciation)
9,495.43
9,471.67
8,258.98
7,952.13
7,222.55
8,003.11
6,949.18
Operating Profit (PBDIT) excl Other Income
1571.9
1693.8
1245.6
1043.6
1167
1241
1128.8
Other Income
174.63
145.28
177.18
100.88
77.00
54.61
61.76
Operating Profit (PBDIT)
2,543.32
2,536.55
1,978.13
1,612.38
1,612.12
1,656.14
1,542.56
Interest
16.77
16.97
11.95
12.55
4.21
10.55
9.32
Exceptional Items
-58.72
-17.95
18.31
-23.72
-15.15
-23.29
-1.56
Gross Profit (PBDT)
6,016.78
6,053.69
4,906.49
4,713.35
5,066.93
5,657.28
4,925.49
Depreciation
756.29
690.01
565.79
470.55
378.03
360.74
347.55
Profit Before Tax
1,711.55
1,811.62
1,418.69
1,105.56
1,214.73
1,261.57
1,184.13
Tax
215.94
272.71
201.27
149.06
201.52
195.34
194.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,627.72
1,670.38
1,180.06
935.69
1,005.16
1,055.12
968.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,627.72
1,670.38
1,180.06
935.69
1,005.16
1,055.12
968.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
23.02
-6.29
53.59
36.45
8.33
11.33
20.86
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,650.74
1,664.09
1,233.65
972.13
1,013.50
1,066.46
989.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
10,407.86
12,213.33
10,556.44
9,905.50
9,277.24
8,602.51
7,839.92
Earnings per share (EPS)
1.58
1.63
1.14
0.9
0.96
1.01
0.93
Diluted Earnings per share
1.58
1.63
1.14
0.9
0.96
1.01
0.93
Operating Profit Margin (Excl OI)
14.57%
15.24%
13.0%
11.57%
13.79%
13.42%
14.03%
Gross Profit Margin
22.3%
22.41%
20.88%
17.52%
18.99%
17.55%
18.96%
PAT Margin
14.71%
14.96%
12.42%
10.4%
11.98%
11.41%
11.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -0.88% vs 17.47% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -0.81% vs 34.89% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -0.95% vs 32.78% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -1.18% vs 42.86% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of China Resources Double-Crane Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
11,067.33
0
11,067.33
Other Operating Income
0.00
0.00
0.00
Total Operating income
11,067.33
0
11,067.33
Raw Material Cost
5,050.55
0
5,050.55
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
16.77
0
16.77
Selling and Distribution Expenses
3,889.69
0
3,889.69
Other Expenses
53.84
0.00
53.84
Total Expenditure (Excl Depreciation)
9,495.43
0
9,495.43
Operating Profit (PBDIT) excl Other Income
1,571.89
0.00
1,571.89
Other Income
174.63
0
174.63
Operating Profit (PBDIT)
2,543.32
0
2,543.32
Interest
16.77
0
16.77
Exceptional Items
-58.72
0
-58.72
Gross Profit (PBDT)
6,016.78
0
6,016.78
Depreciation
756.29
0
756.29
Profit Before Tax
1,711.55
0
1,711.55
Tax
215.94
0
215.94
Provisions and contingencies
0
0
0.00
Profit After Tax
1,627.72
0
1,627.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,627.72
0
1,627.72
Share in Profit of Associates
0
0
0.00
Minority Interest
23.02
0
23.02
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,650.74
0
1,650.74
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
10,407.86
0
10,407.86
Earnings per share (EPS)
1.58
0
1.58
Diluted Earnings per share
1.58
0
1.58
Operating Profit Margin (Excl OI)
14.57%
0%
0.00
14.57%
Gross Profit Margin
22.30%
0%
0.00
22.30%
PAT Margin
14.71%
0%
0.00
14.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,106.73 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -0.88% vs 17.47% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 165.07 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -0.81% vs 34.89% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 236.87 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -0.95% vs 32.78% in Dec 2023

Annual - Interest
Interest 1.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.18% vs 42.86% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.57%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023